| Turchia | Austria | Spagna | |
| Radioterapia per il cancro colorettale | da $7,000 | da $12,000 | da $10,000 |
| Chemioterapia per carcinoma mammario | da $1,200 | da $15,000 | da $3,500 |
Il medico è un oncologo pediatrico premiato, specializzato in sarcomi ossei e dei tessuti molli. Come capo del Dipartimento di Ematologia Oncologica presso Sant Joan De Déu, un ospedale pediatrico leader in Europa, il medico fornisce trattamenti per neuroblastomi, gliomi, sarcomi di Ewing e tumori di Wilms.<\/p>
Formatosi negli Stati Uniti, il medico ha completato borse di studio in ematologia oncologica pediatrica e patologia molecolare del cancro pediatrico presso Weill Cornell Medicine e Memorial Sloan Kettering Cancer Center. Il medico ha scritto oltre 70 articoli e ha sviluppato un trattamento non radiativo per i gliomi del midollo spinale.<\/p>
Il medico possiede una laurea in Medicina presso l'Università Complutense di Madrid e un dottorato presso l'Università di Barcellona. Specializzandosi in Ematologia e Oncologia Pediatrica presso l'Università del Maryland, il medico è esperto nel trattamento di tumori ossei e cerebrali, nonché di leucemia e malattie ematologiche.<\/p>
Con oltre due decenni di esperienza, il medico attualmente dirige l'Unità di Ematologia e Oncologia Pediatrica presso l'Ospedale HM Montepríncipe, concentrandosi sulla cura di bambini e adolescenti. In precedenza, il medico ha ricoperto la stessa posizione presso l'Ospedale Universitario Clínica San Rafael ed è autore di numerose pubblicazioni scientifiche.<\/p>
Il medico è uno specialista esperto in ematologia oncologica pediatrica e un neurochirurgo pediatrico di spicco in Spagna. Con oltre 30 anni di esperienza pratica, il medico guida l'Unità di Ematologia e Oncologia Pediatrica presso HM Hospitales, concentrandosi su gravi malattie ematologiche e cancerose nei bambini e negli adolescenti.<\/p>
Il medico è specializzato nella diagnosi e nel trattamento dei disturbi ematologici e cancerosi, in particolare nei sistemi eritrocitario, mieloide e linfoide. Il medico serve come consulente per l'OMS e l'UNESCO ed è coinvolto in attività di insegnamento e ricerca.<\/p>
Le credenziali educative includono lauree presso l'Universidad Complutense de Madrid, l'Università di Barcellona e l'Università del Maryland.<\/p>
Il medico è un oncologo pediatrico con 37 anni di esperienza, specializzato nel trattamento dei disturbi del sangue e nell'esecuzione di procedure come i trapianti di midollo osseo e la terapia ablativa. Attualmente, il medico è Capo dell'Emato-Oncologia Pediatrica presso l'Ospedale Universitario Quironsalud Madrid.<\/p>
Con un prolifico curriculum accademico, il medico ha curato 14 libri, contribuito a 75 capitoli di libri e presentato a oltre 200 conferenze. Il medico è membro di diverse associazioni professionali, tra cui l'Associazione Spagnola di Ematologia Pediatrica e l'Associazione Spagnola di Oncologia Pediatrica.<\/p>
Il medico tratta un'ampia gamma di condizioni, tra cui leucemia, linfoma, mieloma multiplo e vari disturbi ematologici e autoimmuni.<\/p>
Spanish hospitals utilize the SIOP UMBRELLA protocol for Wilms tumor treatment. This framework involves neoadjuvant chemotherapy before surgical resection to reduce tumor size. This method prevents intraoperative rupture and enables safer surgeries. Leading JCI-accredited centers in Barcelona and Madrid coordinate these pediatric oncology cases.
Bookimed Expert Insight: SJD Barcelona Children’s Hospital stands out by seeing 450,000 patients annually and hosting a dedicated Laboratory for Molecular Medicine. This high volume is critical because Dr. Jaume Mora Graupera and his team use this molecular data to refine the SIOP protocol. They move beyond standard imaging to adjust chemotherapy drug intensity based on specific tumor markers.
Patient Consensus: Parents emphasize that the treatment timeline changes significantly depending on whether the team chooses chemotherapy or surgery first. It is important to confirm early if a high-volume pediatric oncology center will lead the multidisciplinary care.
Whether your child needs the entire kidney removed depends on the tumor size and location. Surgeons in Spain prioritize kidney-sparing surgery whenever safely possible. For large Wilms tumors, a radical nephrectomy is the standard to ensure all cancer cells are removed. The remaining kidney typically compensates for both.
Bookimed Expert Insight: Spain is a global leader for this treatment because centers like SJD Barcelona Children's Hospital use molecular medicine to tailor surgery. Prof. Dr. Jaume Mora Graupera at SJD Barcelona specifically focuses on Wilms tumors with a multidisciplinary approach. Data shows these specialized teams often use pre-op chemotherapy to increase the chances of performing a partial nephrectomy.
Patient Consensus: Parents note that the surgical plan may shift during the operation if the tumor involves the ureter. They emphasize that the healthy kidney adapts quickly, and long-term monitoring becomes the primary focus after recovery.
Spanish hospitals require radiation for Wilms tumor when cancer reaches stage 3 or 4. Specialists also mandate it for high-risk histology or incomplete surgical resection. Following International Society of Paediatric Oncology (SIOP) protocols, radiation targets residual cells after preoperative chemotherapy and surgery.
Bookimed Expert Insight: SJD Barcelona Children's Hospital manages 450,000 patients yearly and leads European pediatric oncology. Their specialists, like Dr. Jaume Mora Graupera, focus on molecular medicine to refine radiation needs. This high volume allows clinics to offer advanced techniques like IMRT, which better protects developing organs in young children.
Patient Consensus: Families note that radiation decisions often change after the final pathology report. They emphasize the importance of daily session logistics, especially for very young children requiring sedation.
Leading Wilms tumor specialists in Spain include Dr. Jaume Mora Graupera at SJD Barcelona Children’s Hospital and Dr. Blanca López-Ibor at HM Madrid. These experts collaborate within Joint Commission International-accredited multidisciplinary teams. They provide surgical resection, chemotherapy, and advanced molecular diagnostics for pediatric nephroblastoma.
Bookimed Expert Insight: While Madrid and Barcelona both offer JCI-accredited care, SJD Barcelona Children’s Hospital serves a massive volume of 450,000 patients annually. This high concentration of pediatric cases allows their dedicated oncology research lab to perform specialized molecular testing. This level of diagnostic depth is often unavailable at general hospitals and is critical for tailoring Wilms tumor treatment protocols.
Patient Consensus: Families note it is vital to select centers with established pediatric solid tumor programs. They emphasize that coordination between surgeons and pathologists must happen quickly to ensure the best results.
Top Spanish hospitals for Wilms tumor treatment include SJD Barcelona Children's Hospital and Centro Médico Teknon. These JCI-accredited centers specialize in pediatric oncology and robotic surgery. Expert teams prioritize multidisciplinary care. They offer advanced molecular diagnostics and personalized chemotherapy protocols for children.
Bookimed Expert Insight: SJD Barcelona stands out by treating over 4,000 children annually. This high volume allows their specialists to manage complex cases that adult-focused hospitals rarely see. While Teknon is a top choice for celebrities, SJD's role as a pediatric-only institution ensures all staff, from radiologists to nurses, are specifically trained in childhood cancer protocols.
Patient Consensus: Patients emphasize finding a dedicated pediatric solid tumor team rather than a general oncology department. Many note it is important to confirm that a specialized pediatric surgeon, not a general surgeon, performs the kidney resection.
Spanish hospitals support international families through dedicated departments that manage medical visas, travel logistics, and multilingual communication. Leading centers utilize JCI-accredited standards to coordinate pediatric oncology care. Dedicated case managers assist with insurance navigation and clinical scheduling to reduce the emotional burden on visiting families.
Bookimed Expert Insight: Spain ranks second globally in patient preference, driven by specialized centers like SJD Barcelona Children’s Hospital which serves 450,000 patients annually. While public centers are experienced, private institutions like Centro Médico Teknon or Hospital Quiron Barcelona offer higher suite availability. Choosing a center with a dedicated Laboratory for Molecular Medicine ensures access to the latest biological insights for pediatric tumors.
Patient Consensus: Parents find that major urban centers offer practical help with lodging and transport through social workers. While language support is available, families notes it is vital to confirm direct insurance billing early to avoid administrative delays.